Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

AstraZeneca and SCRI join to develop targeted anticancer agent

Jan. 13, 2011

BIND Biosciences begins phase I study of BIND-014 in cancer

Jan. 13, 2011

HPRG-induced downregulation of PlGF shows anticancer potential

Jan. 13, 2011

UCB claims new PI3K inhibitors

Jan. 13, 2011

Seattle Genetics and Pfizer join to develop anticancer antibody-drug conjugates

Jan. 12, 2011

Cylene Pharmaceuticals identifies novel protein kinase inhibitors

Jan. 12, 2011

Antimalarial artesunate has anticancer properties that can be enhanced by combination therapy

Jan. 12, 2011

Enrollment begins in phase III regorafenib trial in gastrointestinal stromal tumors

Jan. 11, 2011

Eusa Pharma obtains FDA priority review status for Erwinaze BLA

Jan. 11, 2011

Abraxis claims new proto-oncogene tyrosine-protein kinase Src inhibitors

Jan. 11, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...